000 | 01921 a2200589 4500 | ||
---|---|---|---|
005 | 20250516070306.0 | ||
264 | 0 | _c20120508 | |
008 | 201205s 0 0 eng d | ||
022 | _a1872-7573 | ||
024 | 7 |
_a10.1016/j.jep.2011.11.050 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKo, Yu-Jen | |
245 | 0 | 0 |
_aAntiosteoporotic activity of Davallia formosana. _h[electronic resource] |
260 |
_bJournal of ethnopharmacology _cJan 2012 |
||
300 |
_a558-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlendronate _xpharmacology |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 |
_aAmino Acids _xurine |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiomechanical Phenomena |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xchemistry |
650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
650 | 0 | 4 |
_aCalcium _xurine |
650 | 0 | 4 |
_aCatechin _xpharmacology |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFemur _xdiagnostic imaging |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
650 | 0 | 4 |
_aOsteoporosis _xdiagnostic imaging |
650 | 0 | 4 | _aOvariectomy |
650 | 0 | 4 |
_aPlant Extracts _xchemistry |
650 | 0 | 4 | _aPlants, Medicinal |
650 | 0 | 4 |
_aPolypodiaceae _xchemistry |
650 | 0 | 4 |
_aRANK Ligand _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aRhizome |
650 | 0 | 4 |
_aSolvents _xchemistry |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aX-Ray Microtomography |
700 | 1 | _aWu, Jin-Bin | |
700 | 1 | _aHo, Hui-Ya | |
700 | 1 | _aLin, Wen-Chuan | |
773 | 0 |
_tJournal of ethnopharmacology _gvol. 139 _gno. 2 _gp. 558-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jep.2011.11.050 _zAvailable from publisher's website |
999 |
_c21378614 _d21378614 |